A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
Bright Adu, Noelie Henry, Aissata Barry, Amidou Diarra, Susheel K Singh, Kazutoyo Miura, Carole A Long, Issaka Sagara, Sodiomon B Sirima, Michael Theisen, Alfred B Tiono, Cecilia Carnrot, Karin Lövgren Bengtsson, Jordan L Plieskatt, Alphonse Ouedraogo, Ben Idriss Soulama, Edith C Bougouma, Mohammad Naghizadeh, Jean Baptist B Yaro, Sem Ezinmegnon, Ebenezer Addo Ofori, Augustin Konkobo, Jenny M Reimer, Amidou Ouedraogo, Moussa Tienta, Issa N Ouedraogo
The Journal of clinical investigation 2024;134(7):